AMG 397


AMG 397 is an oral small molecule inhibitor of MCL-1. It is being investigated as a treatment for multiple myeloma, acute myeloid leukemia, and non-hodgkins lymphoma.

SparkCures ID 330
Developed By Amgen
Generic Name AMG 397

Clinical Trials


There are no resources, links or videos to display for this treatment.